These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2345839)

  • 21. A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment.
    Hampson LV; Williamson PR; Wilby MJ; Jaki T
    Stat Methods Med Res; 2018 Dec; 27(12):3612-3627. PubMed ID: 28589752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for determining the size of internal pilot studies.
    Sandvik L; Erikssen J; Mowinckel P; Rødland EA
    Stat Med; 1996 Jul; 15(14):1587-90. PubMed ID: 8855484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
    Friede T; Häring DA; Schmidli H
    Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size determination and re-estimation for matched pair designs with multiple binary endpoints.
    Xu J; Yu M
    Biom J; 2013 May; 55(3):430-43. PubMed ID: 23553605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomizing responders. Cardiac Arrhythmia Suppression Trial (CAST) investigators.
    Hallstrom AP; Verter J; Friedman L
    Control Clin Trials; 1991 Aug; 12(4):486-503. PubMed ID: 1657526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size recalculation in internal pilot study designs: a review.
    Friede T; Kieser M
    Biom J; 2006 Aug; 48(4):537-55. PubMed ID: 16972704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial?
    Whitehead AL; Sully BG; Campbell MJ
    Contemp Clin Trials; 2014 May; 38(1):130-3. PubMed ID: 24735841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials.
    Cooper CL; Whitehead A; Pottrill E; Julious SA; Walters SJ
    Clin Trials; 2018 Apr; 15(2):189-196. PubMed ID: 29361833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
    van Schie S; Moerbeek M
    Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mid-trial design reviews for sequential clinical trials.
    Whitehead J; Whitehead A; Todd S; Bolland K; Sooriyarachchi MR
    Stat Med; 2001 Jan; 20(2):165-76. PubMed ID: 11169595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.